PNC Financial Services Group’s Oramed Pharmaceuticals ORMP Stock Holding History

PNC Financial Services Group’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$72.1K	Hold	21,200	–	–	﹤0.01%	3008
2025 Q4	$60.4K	Sell	21,200 -2,000	-9%	-$5.16K	﹤0.01%	3100
2025 Q3	$61.2K	Hold	23,200	–	–	﹤0.01%	3085
2025 Q2	$52.2K	Sell	23,200 -3,000	-11%	-$6.62K	﹤0.01%	3088
2025 Q1	$56.1K	Hold	26,200	–	–	﹤0.01%	3036
2024 Q4	$63.4K	Hold	26,200	–	–	﹤0.01%	2961
2024 Q3	$63.9K	Hold	26,200	–	–	﹤0.01%	2947
2024 Q2	$67.3K	Hold	26,200	–	–	﹤0.01%	2865
2024 Q1	$76.5K	Hold	26,200	–	–	﹤0.01%	2767
2023 Q4	$60.5K	Sell	26,200 -975	-4%	-$2.08K	﹤0.01%	2872
2023 Q3	$70.9K	Buy	27,175 +3,000	+12%	+$9.45K	﹤0.01%	2766
2023 Q2	$86.5K	Hold	24,175	–	–	﹤0.01%	2736
2023 Q1	$52.7K	Buy	24,175 +2,000	+9%	+$6.35K	﹤0.01%	2966
2022 Q4	$267K	Buy	22,175 +975	+5%	+$7.58K	﹤0.01%	1934
2022 Q3	$137K	Hold	21,200	–	–	﹤0.01%	2334
2022 Q2	$97K	Hold	21,200	–	–	﹤0.01%	2598
2022 Q1	$183K	Hold	21,200	–	–	﹤0.01%	2322
2021 Q4	$303K	Hold	21,200	–	–	﹤0.01%	2001
2021 Q3	$466K	Hold	21,200	–	–	﹤0.01%	1650
2021 Q2	$284K	Hold	21,200	–	–	﹤0.01%	1996
2021 Q1	$215K	Hold	21,200	–	–	﹤0.01%	2133
2020 Q4	$90K	Hold	21,200	–	–	﹤0.01%	2559
2020 Q3	$55K	Hold	21,200	–	–	﹤0.01%	2685
2020 Q2	$75K	Hold	21,200	–	–	﹤0.01%	2517
2020 Q1	$64K	Hold	21,200	–	–	﹤0.01%	2480
2019 Q4	$109K	Hold	21,200	–	–	﹤0.01%	2437
2019 Q3	$68K	Hold	21,200	–	–	﹤0.01%	2748
2019 Q2	$76K	Hold	21,200	–	–	﹤0.01%	2696
2019 Q1	$77K	Hold	21,200	–	–	﹤0.01%	2710
2018 Q4	$64K	Hold	21,200	–	–	﹤0.01%	2728
2018 Q3	$103K	Hold	21,200	–	–	﹤0.01%	2584
2018 Q2	$158K	Hold	21,200	–	–	﹤0.01%	2340
2018 Q1	$138K	Hold	21,200	–	–	﹤0.01%	2380
2017 Q4	$191K	Hold	21,200	–	–	﹤0.01%	2221
2017 Q3	$211K	Hold	21,200	–	–	﹤0.01%	2116
2017 Q2	$165K	Hold	21,200	–	–	﹤0.01%	2242
2017 Q1	$130K	Hold	21,200	–	–	﹤0.01%	2352
2016 Q4	$130K	Hold	21,200	–	–	﹤0.01%	2324
2016 Q3	$154K	Buy	21,200 +7,393	+54%	+$57.5K	﹤0.01%	2237
2016 Q2	$115K	Hold	13,807	–	–	﹤0.01%	2397
2016 Q1	$92K	Buy	13,807 +11,089	+408%	+$74.2K	﹤0.01%	2522
2015 Q4	$23K	Hold	2,718	–	–	﹤0.01%	3235
2015 Q3	$15K	Hold	2,718	–	–	﹤0.01%	3508
2015 Q2	$15K	Buy	+2,718	New	+$18.6K	﹤0.01%	3630

Other funds holding ORMP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PNC Financial Services Group's ORMP Position: Q1 2026 in Review

PNC Financial Services Group held its Oramed Pharmaceuticals (ORMP) position steady in Q1 2026 at 21,200 shares worth $72.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

PNC Financial Services Group first reported a position in ORMP in Q2 2015 and has held it in 44 quarters since. The position peaked at $466K in Q3 2021. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

PNC Financial Services Group held 21,200 shares of Oramed Pharmaceuticals worth $72.1K as of Q1 2026.
PNC Financial Services Group left its Oramed Pharmaceuticals share count unchanged in Q1 2026.
Oramed Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3008 holding.
PNC Financial Services Group first reported a position in Oramed Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
PNC Financial Services Group's Oramed Pharmaceuticals position peaked at $466K in Q3 2021.
64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.